Chronic itch is one of medicine’s most stubborn and least glamorous problems, and for millions of patients it never fully goes away. A new preliminary study from Turkey now suggests that the key to understanding some of the worst cases may lie not in the skin itself, but in the mind’s background chatter — the rapid, often negative automatic thoughts that pop into consciousness without deliberate effort. The research, published in the Archives of Dermatological Research, compared patients with lichen simplex chronicus, a condition in which relentless scratching thickens and hardens the skin, against patients with chronic idiopathic pruritus, long-standing itch that arises with no identifiable skin or systemic disease.
The study, conducted by dermatologist Yesim Akpinar Kara of Ankara Training and Research Hospital and psychiatrist Bilge Bilgin Kapucu, enrolled a modest sample: nineteen patients with lichen simplex chronicus and seventeen with chronic idiopathic pruritus, all recruited from a dermatology outpatient clinic. The diagnosis of chronic idiopathic pruritus was made only after excluding systemic illness and identifiable skin disease, while lichen simplex chronicus was diagnosed on clinical grounds and confirmed by skin biopsy of lesional tissue. That biopsy confirmation matters, because it anchors the psychiatric findings to a dermatologically verified condition rather than a loose clinical impression.
To measure the sensation that dominates these patients’ lives, the researchers used the visual analog scale, a simple instrument in which patients rate itch intensity on a continuum. To probe the psychological landscape, they administered two well-established psychiatric instruments: the Brief Psychiatric Rating Scale, a clinician-rated measure of general psychiatric symptomatology developed originally in 1962, and the Automatic Thoughts Questionnaire, a self-report tool rooted in Aaron Beck’s cognitive model of emotional disorders. The questionnaire, developed by Hollon and Kendall in 1980 and validated in Turkish by Şahin and Şahin in 1992, quantifies the frequency of negative automatic thoughts — the self-critical, pessimistic, and catastrophic cognitions that cognitive theory holds to be central in depression and anxiety.
The headline finding is striking precisely because the itch itself was not the differentiator. On the visual analog scale, the two groups were statistically indistinguishable: mean scores were 6.53 for the lichen simplex chronicus group and 6.58 for the chronic idiopathic pruritus group, a difference that failed to reach significance in Kruskal–Wallis testing (p = 0.746). In other words, both groups were suffering from itch of comparable, and considerable, severity — well above the midpoint of the scale. Yet when the researchers turned to the Automatic Thoughts Questionnaire, the groups diverged sharply. Total scores were significantly higher in the lichen simplex chronicus group than in the idiopathic pruritus group (p = 0.011).
That asymmetry — identical itch, different minds — is what makes the study conceptually interesting. Lichen simplex chronicus is, at its core, a scratch-itch cycle made flesh: repeated mechanical trauma to the skin triggers lichenification, the thickened, leathery change that in turn lowers the threshold for further itching and scratching. If patients with this condition carry a heavier load of negative automatic thoughts than patients whose itch has no visible target, it raises the possibility that certain cognitive patterns — rumination, catastrophizing, obsessive attention to bodily sensations — may fuel the compulsive scratching that creates and maintains the lesions. The authors suggest that incorporating psychiatric assessment, particularly evaluation of negative automatic thoughts with the Automatic Thoughts Questionnaire, may be beneficial in clinical management, especially for patients with lichen simplex chronicus.
The psychiatric symptom profiles added further texture. Clinically relevant anxiety and depressive symptoms were observed in both groups, confirming that chronic itch of either type travels in the company of meaningful psychological burden. Previous literature has long hinted at this: studies have documented obsessive-compulsive features and reduced quality of life in lichen simplex chronicus patients, elevated stress and neurotrophin levels in the same population, and heightened anxiety and depression across allergic and non-allergic skin disorders. Population-based work from Norway has linked itch with stress and diminished self-efficacy in adolescents, while studies in psoriasis have tied itch frequency to coping strategies and quality of life. The new findings fit squarely into this tradition but add a specific cognitive variable that most earlier studies did not measure.
Equally notable is what the study did not find. No significant correlation emerged between visual analog scale itch scores and psychiatric symptoms, meaning that how badly a patient itched did not predict how anxious or depressed they were, nor how severe their automatic thoughts were. This decoupling of sensation intensity from psychological distress echoes a recurring theme in psychodermatology: the subjective intensity of a symptom and its psychological consequences are related but separable dimensions. A patient scratching a 6.5 out of 10 itch may be coping well or may be trapped in a spiral of negative thinking, and the itch score alone cannot tell a clinician which.
The study’s limitations are real and the authors are candid in framing the work as preliminary. Thirty-six patients is a small sample, and the statistical comparisons relied on non-parametric testing appropriate to that size, but small samples limit generalizability and statistical power. The cross-sectional design cannot establish direction: do negative automatic thoughts drive scratching and lichenification, or does the visible, disfiguring plaque of lichen simplex chronicus generate shame, rumination, and negative self-talk? Both pathways are plausible, and they are not mutually exclusive — a feedback loop in which cognition and skin reinforce each other would be consistent with everything known about the condition. The absence of a healthy control group also means the study can compare the two itch disorders to each other but cannot say whether either group’s automatic thought burden exceeds that of the general population, although prior work on personality differences in lichen simplex chronicus patients suggests it plausibly does.
Why should the broader scientific readership care? Because chronic itch is a global problem with an enormous unmet therapeutic need. Uremic pruritus in dialysis patients, for example, remains a major burden in end-stage renal disease despite decades of attention, and the International Forum for the Study of Itch has had to construct an entire clinical classification system simply to organize the many forms chronic itch takes. Antihistamines, the lay public’s default remedy, work poorly for most chronic itch, and the pipeline of targeted neuromodulatory therapies is still maturing. If cognitive variables such as automatic thoughts meaningfully stratify patients — identifying, say, the lichen simplex chronicus patient whose scratching is cognitively driven — that opens the door to targeted adjunctive treatments. Cognitive behavioral therapy, which directly targets automatic thoughts, has already shown benefit in conditions as varied as irritable bowel syndrome and rheumatoid arthritis, where negative cognitions amplify symptom burden; itch could plausibly join that list.
The practical message for clinicians is deceptively simple. A dermatologist seeing thickened, scratched skin should consider that the patient’s mental life may be part of the pathology, and a brief questionnaire — thirty items, a few minutes of a patient’s time — may reveal a treatable dimension that a prescription cream will never touch. Conversely, the study reminds psychiatrists that somatic complaints like chronic itch can be the presenting face of anxiety and depression. The authors’ preliminary report does not settle the question of causality, and its sample size forbids sweeping conclusions. But it does something valuable: it takes a familiar clinical observation — that the worst itch often belongs to patients who scratch hardest and think darkest — and gives it a number, a scale, and a p-value. In a field where the skin and the mind have long been treated as separate territories, that is a small but genuine step toward medicine that treats the patient as a single, connected system.
Subject of Research: The relationship between itch severity, negative automatic thoughts, and psychiatric symptoms in lichen simplex chronicus and chronic idiopathic pruritus
Article Title: Evaluation of Itch severity and automatic thoughts in patients with Lichen Simplex Chronicus and Chronic Idiopathic Pruritus: a preliminary report
Article References: Evaluation of Itch severity and automatic thoughts in patients with Lichen Simplex Chronicus and Chronic Idiopathic Pruritus: a preliminary report. (n.d.). https://doi.org/10.1007/s00403-026-04892-1
Image Credits: AI Generated
DOI: 10.1007/s00403-026-04892-1
Keywords: chronic itch, pruritus, lichen simplex chronicus, chronic idiopathic pruritus, automatic thoughts, psychodermatology, anxiety, depression, visual analog scale, cognitive behavioral therapy, dermatology, psychiatry
